Pontus Andell

1.9k total citations
59 papers, 1.1k citations indexed

About

Pontus Andell is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Pontus Andell has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 11 papers in Psychiatry and Mental health. Recurrent topics in Pontus Andell's work include Acute Myocardial Infarction Research (21 papers), Coronary Interventions and Diagnostics (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Pontus Andell is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Coronary Interventions and Diagnostics (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Pontus Andell collaborates with scholars based in Sweden, Denmark and United States. Pontus Andell's co-authors include Sasha Koul, J. G. Smith, Andreas Martinsson, David Erlinge, Charlotte Andersson, Bengt Zöller, Kristina Sundquist, Xinjun Li, Martin Stagmo and Tomas Jernberg and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Pontus Andell

54 papers receiving 1.1k citations

Peers

Pontus Andell
Mehdi Zoghi Türkiye
Amr F. Barakat United States
Ahmed N. Mahmoud United States
Brian G. Kral United States
Mehrtash Hashemzadeh United States
Mehmet Bozbay Türkiye
Vidhu Anand United States
Patrick M. Pullicino United States
Rahul Potluri United Kingdom
Mehdi Zoghi Türkiye
Pontus Andell
Citations per year, relative to Pontus Andell Pontus Andell (= 1×) peers Mehdi Zoghi

Countries citing papers authored by Pontus Andell

Since Specialization
Citations

This map shows the geographic impact of Pontus Andell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pontus Andell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pontus Andell more than expected).

Fields of papers citing papers by Pontus Andell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pontus Andell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pontus Andell. The network helps show where Pontus Andell may publish in the future.

Co-authorship network of co-authors of Pontus Andell

This figure shows the co-authorship network connecting the top 25 collaborators of Pontus Andell. A scholar is included among the top collaborators of Pontus Andell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pontus Andell. Pontus Andell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andell, Pontus, et al.. (2024). Difficulties in running clinical trials on physical activity. European Heart Journal. 45(44). 4765–4765. 1 indexed citations
2.
Dong, Zihan, et al.. (2024). Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based study. RMD Open. 10(3). e004532–e004532. 5 indexed citations
3.
Andell, Pontus, Joakim Alfredsson, David Erlinge, et al.. (2024). Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study. Circulation. 150(11). 826–835. 6 indexed citations
5.
Garcia‐Argibay, Miguel, Paul‐Christian Bürkner, Paul Lichtenstein, et al.. (2024). Methylphenidate and Short-Term Cardiovascular Risk. JAMA Network Open. 7(3). e241349–e241349. 11 indexed citations
6.
Andell, Pontus, Göran Olivecrona, Matthias Götberg, et al.. (2023). Intracoronary Imaging of Proximal Coronary Artery Lesions – A Nationwide Lesion-Level Analysis From SCAAR. Journal of the Society for Cardiovascular Angiography & Interventions. 2(3). 100597–100597. 1 indexed citations
7.
Valdimarsdóttir, Unnur, Thor Aspelund, Arna Hauksdóttir, et al.. (2023). Psychiatric comorbidities in women with cardiometabolic conditions with and without ADHD: a population-based study. BMC Medicine. 21(1). 450–450. 4 indexed citations
8.
Wojdyla, Daniel, Svend Eggert Jensen, Pontus Andell, et al.. (2022). Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials). The American Journal of Cardiology. 178. 11–17. 3 indexed citations
9.
Edfors, Robert, Stefan H. Jacobson, Håkan Wallén, et al.. (2022). Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function. International Journal of Cardiology. 373. 64–71. 6 indexed citations
10.
Berge, Jonas, et al.. (2021). Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality. Journal of Psychiatric Research. 149. 352–358. 12 indexed citations
11.
Edfors, Robert, Lars Lindhagen, Jonas Spaak, et al.. (2020). Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction. Journal of Internal Medicine. 288(5). 581–592. 8 indexed citations
12.
Jensen, Svend Eggert, René Ernst Nielsen, Christoffer Polcwiartek, et al.. (2020). Time Trends in the Use of Coronary Procedures, Guideline-Based Therapy, and All-Cause Mortality following the Acute Coronary Syndrome in Patients with Schizophrenia. Cardiology. 145(7). 401–409. 9 indexed citations
13.
Desta, Liyew, Tomas Jernberg, Pontus Andell, et al.. (2020). Adherence to Beta-Blockers and Long-Term Risk of Heart Failure and Mortality After a Myocardial Infarction. ESC Heart Failure. 8(1). 344–355. 13 indexed citations
14.
Fröbert, Ole, et al.. (2019). Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events. Open Heart. 6(2). e001109–e001109. 3 indexed citations
15.
Andell, Pontus, Johan Sjögren, Gorav Batra, Karolina Szummer, & Sasha Koul. (2017). Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention. European Journal of Cardio-Thoracic Surgery. 52(5). 930–936. 9 indexed citations
17.
Evans, Marie, Juan Jesús Carrero, Karolina Szummer, et al.. (2016). Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction. Journal of the American College of Cardiology. 67(14). 1687–1697. 44 indexed citations
18.
Mohammad, Moman A., Pontus Andell, Matthias Götberg, et al.. (2016). REAL-LIFE ASSESSMENT OF CANGRELOR P2Y12-INHIBITION IN PATIENTS WITH ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 67(13). 542–542. 1 indexed citations
19.
Andell, Pontus, Stefan James, Christopher P. Cannon, et al.. (2015). TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology. 65(10). A114–A114. 1 indexed citations
20.
Martinsson, Andreas, Charlotte Andersson, Pontus Andell, et al.. (2014). Anemia in the general population: prevalence, clinical correlates and prognostic impact. European Journal of Epidemiology. 29(7). 489–498. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026